Dual Glucagon / GLP-1 Receptor Agonist · CAS 2805997-46-8
SYNCHRONIZE Phase 3 Reference · MW 4231.70 g/mol ·Survodutide (BI 456906 / Dual GCGR + GLP-1)
Clinical Overview & Worked Dilution Specifications
Survodutide (10mg Vial) — Summary & Reconstitution Math
Survodutide (BI 456906) is an investigational dual glucagon receptor (GCGR) and GLP-1R agonist (approx. 1:8 GCGR:GLP-1R potency ratio) with a ~110-hour (4.6-day) half-life studied in the SYNCHRONIZE obesity and MASH liver fibrosis clinical trials.
Direct Answer (Survodutide 10mg Vial): Reconstituting a 10 mg Survodutide vial with 2 mL of bacteriostatic water produces a 5 mg/mL solution (50 mcg per U-100 unit). For a 600 mcg (0.6 mg) target dose, draw 12 Units (0.12 mL) on a U-100 syringe (16.66 doses/vial; t½ = 4.6d, steady state Day 20.7).
Clinical Titration Reference
Protocol Dosing Table — Survodutide
| Phase | Dose | Volume | U-100 | Doses |
|---|---|---|---|---|
| 0.6 mg | 0.12 mL | 12 u | 16.6 | |
| 1.2 mg | 0.24 mL | 24 u | 8.3 | |
| 2.4 mg | 0.48 mL | 48 u | 4.1 | |
| 3.6 mg | 0.72 mL | 72 u | 2.7 | |
| 4.8 mg | 0.96 mL | 96 u | 2 |
Select any row button to load that target dose into the syringe calculator and half-life simulator.
Syringe Units by Diluent Volume
Survodutide 10mg — BAC Water Chart
| Dose | +1 mL BAC10 mg/mL | +1.5 mL BAC6.67 mg/mL | +2 mL BAC5 mg/mL | +3 mL BAC3.33 mg/mL |
|---|---|---|---|---|
| 600 mcg | 6 u 0.06 mL | 9 u 0.09 mL | 12 u 0.12 mL | 18 u 0.18 mL |
| 1.2 mg | 12 u 0.12 mL | 18 u 0.18 mL | 24 u 0.24 mL | 36 u 0.36 mL |
| 2.4 mg | 24 u 0.24 mL | 36 u 0.36 mL | 48 u 0.48 mL | 72 u 0.72 mL |
| 3.6 mg | 36 u 0.36 mL | 54 u 0.54 mL | 72 u 0.72 mL | 108 u 1.08 mL |
| 4.8 mg | 48 u 0.48 mL | 72 u 0.72 mL | 96 u 0.96 mL | 144 u 1.44 mL |
More BAC water lowers concentration and gives a wider, easier-to-read draw on the syringe barrel.
Protocol Escalation · Every 7d
t½ 4.6 days (110h)Dose Step Ladder & Steady-State Math
First-Order Superposition Model
Active Systemic Serum Load (Survodutide)
Quick Clinical Reference · 10mg Vial
Common Questions — Survodutide (10mg)
How much bacteriostatic water do I mix with a 10mg Survodutide vial?
Adding 2 mL of bacteriostatic water (0.9% benzyl alcohol) to a 10 mg Survodutide lyophilized vial yields a concentration of 5 mg/mL (50 mcg per U-100 unit). For a 600 mcg (0.6 mg) target dose, draw 12 Units (0.12 mL) on a standard U-100 insulin syringe.
How many units on a U-100 syringe is 600 mcg of Survodutide (10mg vial)?
When a 10 mg Survodutide vial is reconstituted with 2 mL of bacteriostatic water (5 mg/mL), a 600 mcg (0.6 mg) dose equals 0.12 mL, or exactly 12 Units on a 100-unit (1.0 mL) U-100 syringe.
How many doses are in a 10mg Survodutide vial at 600 mcg per dose?
A 10 mg Survodutide vial provides 16.66 nominal doses at 600 mcg (0.6 mg) per draw (10 mg ÷ 0.6 mg = 16.66). Note that post-reconstitution chemical stability varies by peptide sequence, diluent composition, and storage temperature; always consult compound-specific analytical stability data.
What is the elimination half-life and steady-state timeline of Survodutide?
Survodutide (BI 456906 / Dual GCGR + GLP-1) (CAS 2805997-46-8, MW 4231.70 g/mol) has a terminal elimination half-life of 4.6 days (110 hours). Administered every 7 days, systemic serum levels reach pharmacokinetic steady state (~97% equilibrium, 5 half-lives) around Day 20.7 with a 1.53× accumulation ratio (peak 0.92 mg, trough 0.32 mg).
How do I convert Survodutide milligrams (mg) or micrograms (mcg) to U-100 syringe units?
Use the three-step dilution formula: (1) Concentration = 10 mg ÷ 2 mL = 5 mg/mL; (2) Volume (mL) = 0.6 mg ÷ 5 mg/mL = 0.12 mL; (3) U-100 Syringe Units = 0.12 mL × 100 = 12 Units.
Peer-Reviewed Primary Literature
Clinical Trials & Analytical References
<iframe src="https://peplab.wiki/compounds/survodutide" width="100%" height="540" style="border:1px solid #e2ddd5;border-radius:12px" loading="lazy"></iframe>
Complete Protocol Index · 25 Reference Peptides & Blends
Switch peptide or multi-compound blend
Affiliate Partner Directory & Independent Lab Verifiers
Documented & Illustrative $/mg Lookup — Survodutide 10mg
| Affiliate Partner | COA & Verification Status | Vial Price | $ / Labeled mg | Partner Code | Source, Verifier & Supplier |
|---|---|---|---|---|---|
Bergdorf Bioscience EU & US Tracked Dispatch (Ships from Germany · $9.99 US / Free ≥$250) · Active Affiliate · Documented Catalog Price | No public batch COA located as of 2026-11-04 — request lot COA from supplier Pricing: Documented 10mg vial ($149.99 standard list / $15.00/mg; $134.99 / $13.50/mg w/ -10% referral code BIO-QTVGWU) · Pack: 1 vial (10mg lyophilized powder) · Variant link: Single 10mg SKU on supplier product page (10mg SKU status: In Stock) · Price checked: 2026-11-06 · Report date: Unlinked · Checked: Unverified | $134.99(w/ referral code; $149.99 standard list · 10mg SKU) | $13.50/labeled mg (w/ code · $15.00/mg list) | ||
Simms Research US Domestic (Tampa, FL · UK/EU/CA/AU Unconfirmed) · Active Affiliate · Illustrative Price Estimate | No batch-specific report linked here — request lot COA from supplier Pricing: Illustrative estimate (verify live price on supplier site) · Variant link: Catalog homepage link — verify SKU and vial size availability on supplier site · Price checked: Unverified · Report date: Unlinked · Checked: Unverified | ~$99.90(est.) | ~$9.99/mg est. | ||
True Peptides US Fulfillment (UK/EU/CA/AU Shipping Unconfirmed) · Active Affiliate · Illustrative Price Estimate | No batch-specific report linked here — request lot COA from supplier Pricing: Illustrative estimate (verify live price on supplier site) · Variant link: Catalog homepage link — verify SKU and vial size availability on supplier site · Price checked: Unverified · Report date: Unlinked · Checked: Unverified | ~$118.00(est.) | ~$11.80/mg est. | No code needed (Partner Link) |